新药临床试验期间药物警戒和风险控制研究五:我国药物警戒和风险控制监管体系调研与结果分析
杨建红, 左晓春, 智会静, 冯红云, 李浩, 周凌芸, 詹骁靖, 吕心欢, 陈江鹏, 张象麟
中国药事 ›› 2022, Vol. 36 ›› Issue (6) : 644-658.
新药临床试验期间药物警戒和风险控制研究五:我国药物警戒和风险控制监管体系调研与结果分析
({{custom_author.role_cn}}), {{javascript:window.custom_author_cn_index++;}}Research V on Pharmacovigilance and Risk Control During Clinical Trials of New Drugs: A Questionnaire Survey and Result Analysis on Regulatory System of Pharmacovigilance and Risk Control in China
({{custom_author.role_en}}), {{javascript:window.custom_author_en_index++;}}| {{custom_ref.label}} |
{{custom_citation.content}}
{{custom_citation.annotation}}
|
/
| 〈 |
|
〉 |
